BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 2730961)

  • 1. Risk factors and 10-year breast cancer survival in northern Alberta.
    Lees AW; Jenkins HJ; May CL; Cherian G; Lam EW; Hanson J
    Breast Cancer Res Treat; 1989 Mar; 13(2):143-51. PubMed ID: 2730961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for breast cancer in women undergoing mammography.
    Reuter KL; Baker SP; Krolikowski FJ
    AJR Am J Roentgenol; 1992 Feb; 158(2):273-8. PubMed ID: 1729780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics that predict risk of breast cancer before and after the menopause.
    Paffenbarger RS; Kampert JB; Chang HG
    Am J Epidemiol; 1980 Aug; 112(2):258-68. PubMed ID: 7416152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined effect of childbearing, menstrual events, and body size on age-specific breast cancer risk.
    Kampert JB; Whittemore AS; Paffenbarger RS
    Am J Epidemiol; 1988 Nov; 128(5):962-79. PubMed ID: 3189296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproductive and hormonal factors and breast cancer in a Northern Italian population.
    Talamini R; La Vecchia C; Franceschi S; Colombo F; Decarli A; Grattoni E; Grigoletto E; Tognoni G
    Int J Epidemiol; 1985 Mar; 14(1):70-4. PubMed ID: 3988443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer in premenopausal and postmenopausal women.
    Stavraky K; Emmons S
    J Natl Cancer Inst; 1974 Sep; 53(3):647-54. PubMed ID: 4412246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of reproductive factors and use of oral contraceptives in the aetiology of breast cancer in women aged 50 to 74 years.
    Magnusson CM; Persson IR; Baron JA; Ekbom A; Bergström R; Adami HO
    Int J Cancer; 1999 Jan; 80(2):231-6. PubMed ID: 9935204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer among young U.S. women in relation to oral contraceptive use.
    White E; Malone KE; Weiss NS; Daling JR
    J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for pathologically confirmed benign breast disease.
    Parazzini F; La Vecchia C; Franceschi S; Decarli A; Gallus G; Regallo M; Liberati A; Tognoni G
    Am J Epidemiol; 1984 Jul; 120(1):115-22. PubMed ID: 6741913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer before age 45 and oral contraceptive use: new findings.
    Miller DR; Rosenberg L; Kaufman DW; Stolley P; Warshauer ME; Shapiro S
    Am J Epidemiol; 1989 Feb; 129(2):269-80. PubMed ID: 2912040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of breast cancer.
    Marchant DJ
    Clin Obstet Gynecol; 1982 Jun; 25(2):387-92. PubMed ID: 7105514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Can breast cancer be prevented?].
    Vatten LJ
    Tidsskr Nor Laegeforen; 1991 May; 111(14):1745-8. PubMed ID: 2063386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of breast cancer in relation to reproductive factors in Denmark.
    Ewertz M; Duffy SW
    Br J Cancer; 1988 Jul; 58(1):99-104. PubMed ID: 3166899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral contraceptives and breast cancer.
    Brinton LA; Hoover R; Szklo M; Fraumeni JF
    Int J Epidemiol; 1982 Dec; 11(4):316-22. PubMed ID: 7152784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of cholelithiasis during pregnancy and its relationship with age, parity, menarche, breast-feeding, dysmenorrhea, oral contraception and a maternal history of cholelithiasis.
    Basso L; McCollum PT; Darling MR; Tocchi A; Tanner WA
    Surg Gynecol Obstet; 1992 Jul; 175(1):41-6. PubMed ID: 1621198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraceptives and breast cancer.
    Jick H; Walker AM; Watkins RN; D'Ewart DC; Hunter JR; Danford A; Madsen S; Dinan BJ; Rothman KJ
    Am J Epidemiol; 1980 Nov; 112(5):577-85. PubMed ID: 7435486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraception, parity, breast feeding, and severity of rheumatoid arthritis.
    Jorgensen C; Picot MC; Bologna C; Sany J
    Ann Rheum Dis; 1996 Feb; 55(2):94-8. PubMed ID: 8712873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral contraceptives and premenopausal breast cancer in nulliparous women.
    Stadel BV; Lai SH; Schlesselman JJ; Murray P
    Contraception; 1988 Sep; 38(3):287-99. PubMed ID: 3168449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-specific patterns of association between breast cancer and risk factors in black women, ages 20 to 39 and 40 to 54.
    Mayberry RM
    Ann Epidemiol; 1994 May; 4(3):205-13. PubMed ID: 8055121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron status markers, serum ferritin and hemoglobin in 1359 Danish women in relation to menstruation, hormonal contraception, parity, and postmenopausal hormone treatment.
    Milman N; Kirchhoff M; Jørgensen T
    Ann Hematol; 1992 Aug; 65(2):96-102. PubMed ID: 1511065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.